|
Mark A. Klausner, M.D.
Chief Medical Officer
Dr. Klausner has over 25 of years of experience in the pharmaceutical industry. Prior to joining CorMedix, he was Chief Medical Officer at NephroGenex, before which he spent 17 years at Johnson & Johnson where he was a Vice President in several functional areas including Clinical R&D, Medical Affairs and Pharmacovigilance.
Dr. Klausner's accomplishments at J&J include being lead company presenter at 2 public FDA Advisory Committee meetings, the company's primary medical officer for several drug-safety related crises, and leader of clinical development activities across a variety of therapeutic areas.
Prior to his pharmaceutical experience, Dr. Klausner was a member of a private practice, multi-specialty internal medicine group where he was one of two nephrologists with responsibilities for an outpatient dialysis center, in-hospital dialysis and nephrology consultations, and an office-based practice.
Dr. Klausner is board-certified in Internal Medicine and Nephrology. He received his medical degree from Harvard Medical School, did his internship at Columbia Presbyterian Hospital in New York City and then completed his Internal Medicine residency and Nephrology fellowship at Beth Israel Hospital in Boston.
|